Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD)
IPCAVD Contact Information
Michael Pensiero, Ph.D.
Phone: 301-435-3749
Fax: 301-402-3684
E-mail: mpensiero@niaid.nih.gov
Current Awardees
Dan Barouch
Novel adenovirus vector-based vaccines for HIV-1
Beth Israel Deaconess Medical Center
Dan Barouch
Novel heterologous adenovirus prime-boost HIV-1 vaccine
Beth Israel Deaconess Medical Center
Hildegund Ertl
HIV-1 Vaccine based on chimp serotypes of Adenovirus
Wistar Institute
Mark Feinberg
Optimizing the immunogenicity of MVA-based AIDS vaccine
Emory University
Harriet Robinson
GM-CSF-adjuvanted Clade C DNA/MVA and MVA/MVA vaccines
Geovax, Inc.
Shan Lu
Optimization of HIV vaccines for the induction of cross-reactive antibodies
University of Massachusetts Medical School, Worcester
back to top